0,955  0,003  Chemoprotective
0,952  0,002  Chemopreventive
0,950  0,001  Antimutagenic
0,942  0,002  Antihypercholesterolemic
0,929  0,002  NOS2 expression inhibitor
0,928  0,002  Monophenol monooxygenase inhibitor
0,917  0,001  Melanin inhibitor
0,910  0,006  Alpha-glucosidase inhibitor
0,877  0,004  Caspase 9 stimulant
0,879  0,008  Transcription factor NF kappa B inhibitor
0,867  0,001  Amylase inhibitor
0,862  0,005  Antidiabetic
0,862  0,005  Cyclophilin D inhibitor
0,857  0,004  Antioxidant
0,852  0,003  Proliferative diseases treatment
0,848  0,002  Sulfotransferase substrate
0,843  0,012  Apoptosis agonist
0,838  0,011  Antiinflammatory
0,829  0,007  TNF expression inhibitor
0,821  0,004  UGT1A9 substrate
0,807  0,004  Free radical scavenger
0,793  0,002  VCAM1 expression inhibitor
0,781  0,005  Mutagenic
0,770  0,004  Antiamyloidogenic
0,766  0,004  NOS3 expression inhibitor
0,755  0,004  Cardioprotectant
0,741  0,004  UGT1A1 substrate
0,738  0,003  NOS3 expression enhancer
0,727  0,007  Sensitization
0,722  0,004  Antipyretic
0,719  0,004  Genotoxic
0,715  0,004  Antihypoxic
0,711  0,004  Skin whitener
0,704  0,005  Hypoglycemic
0,699  0,006  Nitric oxide antagonist
0,696  0,009  Antibacterial
0,682  0,005  Amyloid beta aggregation inhibitor
0,676  0,006  Caspase 3 stimulant
0,672  0,005  Apoptosis antagonist
0,670  0,010  Antithrombotic
0,640  0,003  Beta glucuronidase inhibitor
0,628  0,006  Vasodilator, coronary
0,636  0,020  Antileukemic
0,618  0,003  Neurotrophic factor enhancer
0,639  0,029  Antineoplastic (breast cancer)
0,615  0,006  Angiogenesis stimulant
0,624  0,019  Alzheimer's disease treatment
0,618  0,016  Cholesterol antagonist
0,604  0,003  Protein kinase stimulant
0,608  0,007  UDP-glucuronosyltransferase substrate
0,609  0,010  Hepatic disorders treatment
0,595  0,005  Antihypertriglyceridemic
0,587  0,004  UGT2B4 substrate
0,588  0,011  Antiparasitic
0,583  0,006  Vascular (periferal) disease treatment
0,598  0,024  Teratogen
0,587  0,017  Vasodilator, peripheral
0,569  0,013  Antiosteoporotic
0,560  0,005  ICAM1 expression inhibitor
0,565  0,016  Cytotoxic
0,574  0,031  CYP3A4 substrate
0,550  0,008  Antihelmintic
0,558  0,018  Bone diseases treatment
0,545  0,005  Hepatoprotectant
0,537  0,003  Antihemorrhagic
0,547  0,020  Antipruritic, allergic
0,530  0,012  DNA damaging
0,537  0,022  5 Hydroxytryptamine release stimulant
0,510  0,005  Lipid peroxidase inhibitor
0,523  0,018  Antifungal
0,521  0,017  Antineoplastic (brain cancer)
0,529  0,026  Immunosuppressant
0,529  0,028  Embryotoxic
0,525  0,028  Prostate cancer treatment
0,496  0,004  Xanthine oxidase inhibitor
0,510  0,023  Carcinogenic
0,499  0,012  Vasodilator
0,506  0,020  AR expression inhibitor
0,505  0,020  Cytostatic
0,517  0,033  CYP2C9 substrate
0,483  0,004  Cystathionine beta-synthase inhibitor
0,521  0,042  Antineoplastic (lung cancer)
0,504  0,035  Antineoplastic (colorectal cancer)
0,490  0,030  Respiratory analeptic
0,467  0,008  Interferon gamma antagonist
0,488  0,031  Immunostimulant
0,472  0,015  UGT1A6 substrate
0,471  0,016  Antineoplastic (lymphoma)
0,478  0,026  Antineoplastic (melanoma)
0,450  0,008  Antihypotensive
0,459  0,022  Antiprotozoal (Leishmania)
0,473  0,037  Antineoplastic (colon cancer)
0,448  0,014  Myocardial infarction treatment
0,438  0,008  Topoisomerase II inhibitor
0,440  0,012  Cyclic AMP phosphodiesterase inhibitor
0,444  0,023  Antidiabetic (type 2)
0,448  0,029  Antineoplastic (cervical cancer)
0,457  0,038  Stroke treatment
0,434  0,019  Interleukin 2 agonist
0,442  0,030  Lipoprotein disorders treatment
0,457  0,046  Histamine release inhibitor
0,436  0,030  Antineoplastic (pancreatic cancer)
0,423  0,018  Antineoplastic (osteosarcoma)
0,434  0,030  Antineoplastic (glioma)
0,431  0,031  Analeptic
0,435  0,037  Antineoplastic (ovarian cancer)
0,421  0,023  Tumour necrosis factor alpha release inhibitor
0,402  0,010  Antipruritic, non-allergic
0,394  0,005  Topoisomerase I inhibitor
0,429  0,045  Angiogenesis inhibitor
0,410  0,026  Antineoplastic (glioblastoma multiforme)
0,383  0,001  Sodium/glucose cotransporter inhibitor
0,409  0,037  Radioprotector
0,375  0,004  Estrogen agonist
0,395  0,024  Antineoplastic (liver cancer)
0,446  0,082  Antineoplastic (solid tumors)
0,368  0,005  Aldose reductase substrate
0,379  0,018  Antineoplastic (sarcoma)
0,365  0,007  Antihelmintic (Nematodes)
0,394  0,042  CYP2C19 substrate
0,355  0,005  Mediator release inhibitor
0,353  0,003  Estrogen receptor beta agonist
0,353  0,005  Cyclooxygenase 3 inhibitor
0,365  0,018  Antiviral (Herpes)
0,361  0,017  Platelet adhesion inhibitor
0,373  0,030  Antidiabetic symptomatic
0,347  0,004  AMP-activated protein kinase stimulant
0,347  0,005  Estrogen antagonist
0,389  0,047  Immunomodulator
0,338  0,004  Selectin antagonist
0,336  0,005  Carbonic anhydrase XIII inhibitor
0,397  0,067  Antiobesity
0,394  0,065  CYP2C19 inhibitor
0,329  0,004  Histone deacetylase SIRT1 stimulant
0,329  0,004  Histone deacetylase stimulant
0,363  0,041  Hypoxia-inducible factor 1 alpha inhibitor
0,330  0,008  Antifungal enhancer
0,328  0,007  Expectorant
0,349  0,029  Interleukin agonist
0,338  0,021  Antiviral (Influenza)
0,366  0,049  Antiischemic
0,321  0,013  Diabetic nephropathy treatment
0,320  0,015  UGT2B15 substrate
0,339  0,038  Hypolipemic
0,309  0,009  Nitric-oxide synthase stimulant
0,354  0,054  Antimycobacterial
0,338  0,039  Antineoplastic (renal cancer)
0,297  0,006  Beta amyloid protein antagonist
0,337  0,046  Huntington's disease treatment
0,310  0,021  Peptidyltransferase inhibitor
0,322  0,037  DNA synthesis inhibitor
0,290  0,004  Antiviral (Influenza B)
0,294  0,010  Antitussive
0,293  0,014  Antidiarrheal
0,285  0,006  Carbonic anhydrase III inhibitor
0,325  0,049  Antineoplastic (non-small cell lung cancer)
0,274  0,001  Sodium/glucose cotransporter 2 inhibitor
0,353  0,081  Ulceration
0,359  0,087  Antiprotozoal
0,328  0,059  Metabolic disease treatment
0,286  0,019  Liver fibrosis treatment
0,295  0,030  P-glycoprotein inhibitor
0,270  0,006  Estrogen receptor beta antagonist
0,361  0,098  Antiparkinsonian
0,297  0,035  Septic shock treatment
0,329  0,067  CYP2D6 substrate
0,280  0,018  Antidote
0,315  0,053  CYP1A2 inhibitor
0,298  0,044  Antiulcerative
0,314  0,063  Antineoplastic (small cell lung cancer)
0,265  0,014  Psychosexual dysfunction treatment
0,305  0,062  Antineoplastic (multiple myeloma)
0,258  0,016  DNA polymerase I inhibitor
0,260  0,018  Glutathione S-transferase substrate
0,294  0,054  Platelet antagonist
0,257  0,019  Antidiabetic (type 1)
0,241  0,010  Dementia treatment
0,245  0,018  Hexokinase inhibitor
0,237  0,010  Vascular dementia treatment
0,236  0,011  Antifungal (Cryptococcus)
0,242  0,018  Alkylator
0,223  0,001  Sodium/glucose cotransporter 1 inhibitor
0,251  0,030  Protein-tyrosine phosphatase inhibitor
0,238  0,019  Protein-tyrosine phosphatase 1B inhibitor
0,243  0,024  Acute respiratory distress syndrome (ARDS) treatment
0,226  0,012  Choleretic
0,294  0,084  Antineoplastic (endocrine cancer)
0,255  0,045  DNA methylase inhibitor
0,246  0,037  Insulin sensitizer
0,219  0,011  Carbonic anhydrase VI inhibitor
0,241  0,032  Antineoplastic (squamous cell carcinoma)
0,336  0,128  Antiarthritic
0,233  0,030  Antiviral (Influenza A)
0,210  0,007  Postmenopausal disorders treatment
0,207  0,005  Toll-Like receptor 4 antagonist
0,220  0,023  SULT1A3 substrate
0,216  0,024  Cell wall synthesis inhibitor
0,206  0,014  Topoisomerase II alpha inhibitor
0,307  0,117  Atherosclerosis treatment
0,191  0,005  Phosphodiesterase 6D inhibitor
0,237  0,052  DNA methyltransferase I inhibitor
0,194  0,010  DNA repair enzyme inhibitor
0,266  0,082  Antituberculosic
0,186  0,004  Antibiotic Glycopeptide-like
0,208  0,026  Aldehyde dehydrogenase inhibitor
0,202  0,021  Antineoplastic antibiotic
0,219  0,038  Restenosis treatment
0,248  0,068  Antineoplastic (lymphocytic leukemia)
0,187  0,010  Thioredoxin inhibitor
0,212  0,034  Interleukin 6 antagonist
0,209  0,031  Insulin secretagoues
0,195  0,019  UDP-glucose 4-epimerase inhibitor
0,265  0,088  CYP1A2 substrate
0,237  0,065  Antimitotic
0,224  0,052  UGT2B7 substrate
0,224  0,056  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,201  0,034  Cyclooxygenase 1 inhibitor
0,226  0,060  Sedative
0,209  0,047  LDLR expression enhancer
0,219  0,058  Non-steroidal antiinflammatory agent
0,179  0,018  Photosensitizer
0,165  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,176  0,020  Mucolytic
0,204  0,050  Thrombolytic
0,162  0,010  Aldose reductase inhibitor
0,198  0,046  Muscular dystrophy treatment
0,256  0,104  CTGF expression inhibitor
0,171  0,020  Antineoplastic (uterine cancer)
0,170  0,022  UGT2B1 substrate
0,178  0,033  Cholesterol synthesis inhibitor
0,235  0,098  Spasmolytic
0,150  0,016  Transcription factor NF kappa B stimulant
0,152  0,019  Antibiotic
0,184  0,053  ATPase inhibitor
0,157  0,027  Constipation treatment
0,135  0,006  Estrogen receptor alpha agonist
0,142  0,013  Estrogen receptor alpha antagonist
0,131  0,002  Cholesterol absorption inhibitor
0,186  0,058  Antirickettsial
0,149  0,022  Carcinogenic, group 2A
0,185  0,059  UGT1A3 substrate
0,192  0,066  Antiviral (Hepatitis)
0,136  0,013  Lipase inhibitor
0,132  0,011  Na+ K+ transporting ATPase inhibitor
0,204  0,082  Antialcoholic
0,173  0,054  Carcinogenic, group 1
0,139  0,020  SULT1E1 substrate
0,139  0,020  NADH dehydrogenase inhibitor
0,130  0,012  Antiviral (Dengue virus)
0,163  0,048  Acetylcholinesterase inhibitor
0,147  0,032  HDL-cholesterol increasing
0,229  0,114  Lipoxygenase inhibitor
0,164  0,050  Renal failure treatment
0,165  0,052  Hemostatic
0,150  0,038  Microtubule formation inhibitor
0,223  0,113  Radiosensitizer
0,164  0,054  MAO inhibitor
0,250  0,140  Antiprotozoal (Plasmodium)
0,195  0,091  Antineoplastic enhancer
0,134  0,032  Electron transport complex I inhibitor
0,145  0,044  Vanilloid 1 agonist
0,200  0,099  RNA-directed DNA polymerase inhibitor
0,155  0,055  Neurotrophic factor
0,161  0,062  Cyclooxygenase inhibitor
0,186  0,088  Antiviral (Ebola)
0,100  0,004  Heparanase inhibitor
0,142  0,048  Growth stimulant
0,124  0,030  Actinic keratosis treatment
0,152  0,059  Adenylate cyclase stimulant
0,121  0,028  Interleukin 12 antagonist
0,115  0,023  ATPase (Vacuolar H+) inhibitor
0,161  0,069  Neuropathy treatment
0,152  0,062  Contraceptive
0,147  0,057  Alpha-N-acetylglucosaminidase inhibitor
0,096  0,007  Alpha-mannosidase inhibitor
0,144  0,055  Interleukin 4 antagonist
0,110  0,022  HIV-1 integrase (3'-Processing) inhibitor
0,169  0,081  Antineoplastic (gastric cancer)
0,172  0,086  Wound healing agent
0,152  0,067  Hair growth stimulant
0,150  0,069  Antineoplastic (carcinoma)
0,084  0,004  Antibiotic Aminoglycoside-like
0,086  0,009  Glucose-6-phosphate translocase inhibitor
0,106  0,029  Phosphofructokinase-1 inhibitor
0,094  0,018  Neuraminidase inhibitor
0,083  0,008  Mannosidase inhibitor
0,135  0,062  Antihelmintic (Trematoda)
0,161  0,088  Myocardial ischemia treatment
0,136  0,063  Toll-Like receptor 2 antagonist
0,131  0,059  Adenylate cyclase inhibitor
0,139  0,067  Antiacne
0,141  0,070  Heat shock protein 70 antagonist
0,087  0,017  Protein 50S ribosomal subunit inhibitor
0,112  0,042  UGT2B11 substrate
0,096  0,027  Narcotic antagonist
0,083  0,016  Carbonic anhydrase XIV inhibitor
0,127  0,061  Cell adhesion inhibitor
0,091  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,101  0,037  NAD(P)H dehydrogenase (quinone) inhibitor
0,086  0,022  Neuraminidase (influenza) inhibitor
0,076  0,014  Carbonic anhydrase VII inhibitor
0,147  0,086  Hearing loss treatment
0,102  0,041  Antispirochetal
0,149  0,090  Antiviral (Hepatitis C)
0,064  0,005  Protein 30S ribosomal subunit inhibitor
0,114  0,055  Multidrug resistance-associated protein 1 inhibitor
0,077  0,020  Fatty acid synthase inhibitor
0,112  0,056  MAO A inhibitor
0,074  0,019  Phosphorylase inhibitor
0,146  0,091  Prostatic (benign) hyperplasia treatment
0,092  0,038  Thioredoxin reductase inhibitor
0,127  0,073  Cyclooxygenase 2 inhibitor
0,088  0,035  SULT1A2 substrate
0,077  0,024  Antimycoplasmal
0,090  0,038  T cell inhibitor
0,085  0,033  Antitreponemal
0,100  0,049  Antiviral (Rhinovirus)
0,130  0,080  Histone deacetylase SIRT1 inhibitor
0,133  0,087  Antiprotozoal (Coccidial)
0,059  0,019  Glucose-6-phosphate isomerase inhibitor
0,092  0,054  Ornithine decarboxylase inhibitor
0,150  0,114  Antineoplastic (bone cancer)
0,095  0,058  Uric acid excretion stimulant
0,105  0,069  DNA intercalator
0,114  0,081  Contraceptive female
0,091  0,058  Triose-phosphate isomerase inhibitor
0,165  0,132  Antiviral (HIV)
0,056  0,024  Squalene epoxidase inhibitor
0,056  0,025  Topoisomerase II beta inhibitor
0,115  0,085  Tubulin antagonist
0,054  0,025  Factor III inhibitor
0,054  0,027  Equilibrative nucleoside transport protein inhibitor
0,090  0,065  Alcohol dehydrogenase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,064  0,041  Nitric oxide donor
0,062  0,039  Heme oxygenase stimulant
0,032  0,009  Toll-Like receptor 4 agonist
0,031  0,008  Dopamine D1 agonist
0,136  0,114  Diabetic retinopathy treatment
0,101  0,078  SULT1A1 substrate
0,088  0,066  Antineoplastic, alkylator
0,057  0,036  Protein kinase C eta inhibitor
0,108  0,089  Alcohol dehydrogenase substrate
0,115  0,095  Papain-like protease (SARS coronavirus) inhibitor
0,058  0,041  Lipocortins synthesis agonist
0,039  0,023  Arginase inhibitor
0,119  0,103  Mannose-6-phosphate isomerase inhibitor
0,141  0,126  Phospholipase C inhibitor
0,056  0,041  Postcoital contraceptive
0,101  0,086  TRPA1 agonist
0,064  0,052  Hypercalcemia treatment
0,020  0,008  Telomerase stimulant
0,081  0,070  Interleukin 5 antagonist
0,041  0,030  Hypogonadism treatment
0,060  0,050  Leukotriene antagonist
0,028  0,019  1,3-Beta-glucan synthase inhibitor
0,082  0,073  MAO B inhibitor
0,034  0,025  HMG CoA reductase inhibitor
0,091  0,082  Carbonic anhydrase XV inhibitor
0,129  0,121  CF transmembrane conductance regulator agonist
0,033  0,027  Tubulin agonist
0,122  0,116  UGT2B9 substrate
0,082  0,078  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,041  0,039  Microtubule stabilization
0,022  0,020  Adenosine A1 receptor agonist
0,080  0,079  Paget's disease treatment
0,115  0,115  Cholinergic

